Our Products
Catheter Platform Technologies
Two complementary catheter platforms designed to deliver irreversible electroporation therapy through different clinical approaches, targeting severe and hard-to-treat cancers.
DuCath™
Intraductal Electroporation Catheter
The DuCath is designed primarily for a focus on pancreatic & bile duct pre-cancerous lesions.
- Ultra-thin catheter engineered for safe navigation through fragile duct anatomy
- Dense ring electrode layout
- Enables precise electroporation directly at the disease site
- Designed to integrate seamlessly into existing endoscopic workflows
Primary focus: Pancreatic & bile duct cancers
PonCath™
Pediatric Brainstem Tumor Electroporation Catheter
The PonCath enables electroporation treatment of pediatric brainstem tumours, including diffuse intrinsic pontine glioma (DIPG) (concept).
- Next-generation, ultra-thin stereotactic probe concept for treating highly sensitive neural structures
- Designed for extreme precision in delicate brain anatomy
- Enables electroporation where surgery and thermal ablation are not viable
Primary focus: Pediatric brainstem tumours, including diffuse intrinsic pontine glioma (DIPG)
PenCath™
Penetrating Duct-Wall Electroporation Catheter
- Enables targeted treatment of tumours located adjacent to, but not inside the duct lumen
- Allows localised treatment while preserving critical nearby structures
- Designed for highly constrained anatomical environments
- Addresses limitations of conventional ablation technologies
Primary focus: Pancreatic and bile duct tumours that are inaccessible from within the lumen alone
Complementary Platforms, Unified Vision
Together, DuCath, PonCath, and PenCath cover a wide range of clinical scenarios, from intraductal treatment of pre-cancerous lesions to stereotactic delivery for brainstem tumours and penetrating approaches for duct-adjacent tumours.
Partner With Us to Advance Cancer Treatment
Whether you are a medical professional, potential partner, or investor, we welcome the opportunity to discuss how Embio Medical is transforming cancer care.